Predictive Value of Prostate-specific Antigen Expression in Prostate Cancer: A Tissue Microarray Study

Urology

Volumn 74, Issue 5, 2009, Pages 1169-1173

  Erbersdobler, Andreas ^a,b   Isbarn, Hendrik ^b   Steiner, Isabel ^a   Schlomm, Thorsten ^b   Chun, Felix ^b   Mirlacher, Martina ^b   Sauter, Guido ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; TISSUE MICROARRAY; UNIVARIATE ANALYSIS;

ADULT; AGED; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 70350572924     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.02.061     Document Type: Article

References (21)

1. Freedland S.J., Hotaling J.M., Fitzsimons N.J., et al. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes-results from the SEARCH database. Eur Urol 53 (2008) 758-764
2. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317 (1987) 909-916
3. Lilja H., Ulmert D., and Vickers A.J. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer 8 (2008) 268-278
4. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 58 (2001) 843-848
5. Stamey T.A., Johnstone I.M., McNeal J.E., et al. Preoperative serum prostate specific antigen levels between 2 and 22 ng/ml correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng/ml. J Urol 167 (2002) 103-111
6. Hameed O., and Humphrey P.A. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 22 (2005) 88-104
7. Aihara M., Lebovitz R.M., Wheeler T.M., et al. Prostate specific antigen and Gleason grade: an immunohistochemical study of prostate cancer. J Urol 151 (1994) 1558-1564
8. Weir E.G., Partin A.W., and Epstein J.I. Correlation of serum prostate specific antigen and quantitative immunohistochemistry. J Urol 163 (2000) 1739-1742
9. Augustin H., Hammerer P.G., Graefen M., et al. Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy. J Cancer Res Clin Oncol 129 (2003) 662-668
10. Sauvageot J., and Epstein J.I. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy. Prostate 34 (1998) 29-33
11. Berner A., Harvei S., Tretli S., et al. Prostatic carcinoma: a multivariate analysis of prognostic factors. Br J Cancer 69 (1994) 924-930
12. Bai X.Z., Masters J.R., O'Donoghue N., et al. Prognostic markers in clinically localised prostate cancer. Int J Oncol 14 (1999) 785-791
13. Bubendorf L., Nocito A., Moch H., et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 195 (2001) 72-79
14. Hsu S.-M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29 (1981) 577-580
15. Vitali A., Ardoino S., Durante P., et al. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies. Anticancer Res 14 (1994) 1503-1507
16. Noldus J., and Stamey T.A. Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng./ml or less. J Urol 155 (1996) 610-611
17. Erbersdobler A., Augustin H., Schlomm T., et al. Prostate cancers in the transition zone. Part 1: pathological aspects. BJU Int 94 (2004) 1221-1225
18. Noguchi M., Stamey T.A., Neal J.E., et al. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 163 (2000) 1751-1755
19. Wright J.L., and Lange P.H. Newer potential biomarkers in prostate cancer. Rev Urol 9 (2007) 207-213
20. Rubin M.A., Dunn R., Strawderman M., et al. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 26 (2002) 312-319
21. Sakai H., Yogi Y., Minami Y., et al. Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma. J Urol 149 (1993) 1020-1023